Perflutren

CAS 76-19-7 0 current records 1 historicalSmall Molecule

Who holds supplier records for Perflutren? No organisation holds a current US Type II DMF or EU CEP for Perflutren in the registers PharmaTek covers. A further 1 organisation has only historical (inactive) DMF filings.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Perflutren: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/perflutren

Reading the evidence

  • No current DMF or CEP on record

    Only historical filings exist in the covered registers. Any of these organisations may or may not supply today; confirm directly.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Perflutren expires 4 May 2037. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (0)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Perflutren. Country is the organisation's recorded country, not necessarily the manufacturing site.

Not found in the covered registers (FDA DMF list, EDQM). This is not evidence that no supplier exists.

Need Perflutren sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Perflutren are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • MALLINCKRODT INC
    Inactive DMF 12913 · filed Mar 1998

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (2 listed products contain Perflutren). The latest listed patent expires 4 May 2037. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Perflutren is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1663).

Chemical identity

IUPAC name
1,1,1,2,2,3,3,3-octafluoropropane
Canonical SMILES
C(C(F)(F)F)(C(F)(F)F)(F)F
InChIKey
QYSGYZVSCZSLHT-UHFFFAOYSA-N
Synonyms
Definity, Definity rt, DMP 115, DMP-115, DMP115, FS-069, FS069, Luminity, MRX-115, Optison, Perfluoropropane, Perflutren

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Contrast Agent for Ultrasound Imaging
Mechanism of action
Ultrasound Contrast Activity

Record history

PharmaTek records which organisations hold a current DMF or CEP for Perflutren every week, starting 23 Oct 2026. Additions and lapses will appear here from the next weekly release.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

What do the historical Perflutren records mean?

1 organisation has only inactive Type II DMFs for Perflutren. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does the FDA Orange Book list patents for products containing Perflutren?

Yes. The latest patent listed for an approved US product containing Perflutren expires 4 May 2037, across 2 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Perflutren supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Perflutren?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.